Association between atherogenic dyslipidemia and lipid triad with cardiovascular risk scales in 418.343 Spanish workers

被引:3
|
作者
Ignacio Ramirez-Manent, Jose [1 ,2 ,3 ,4 ]
Tomas-Gil, Pilar [4 ]
Coll Villalonga, Josep Lluis [4 ]
Marti-Lliteras, Pau [4 ]
Arturo Lopez-Gonzalez, Angel [2 ,4 ,5 ]
Paublini, Hernan [4 ]
机构
[1] Univ Balearic Islands, Fac Med, Palma De Mallorca 07009, Balearic Island, Spain
[2] Balear Islands Hlth Res Inst Fdn, IDISBA, Palma De Mallorca 07004, Balearic Island, Spain
[3] Balear Islands Hlth Serv, Gen Practitioner Dept, Palma De Mallorca 07003, Balearic Island, Spain
[4] Invest Grp ADEMA SALUD IUNICS, Palma De Mallorca 07003, Balearic Island, Spain
[5] Univ Sch ADEMA, Fac Dent, Palma De Mallorca 07009, Balearic Island, Spain
来源
MEDICINA BALEAR | 2024年 / 39卷 / 01期
关键词
Atherogenic dyslipidemia; cardiovascular disease; cardiovascular risk; atherosclerosis;
D O I
10.3306/AJHS.2024.39.01.9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction and objectives: Cardiovascular diseases in their genesis generally present an anatomopathological process such as atherosclerosis. Atherogenic dyslipidemia (AD) and lipid triad (TL) are parameters that can predict the appearance of atherosclerosis. The aim of this study is to assess the relationship between AD and LT with different cardiovascular risk (CVR) scales. Material and methods: A descriptive, cross-sectional study was carried out in a large sample of Spanish workers, specifically 418343, in which the presence or absence of AD and TL was assessed. Different CVR scales such as REGICOR, SCORE 2, ERICE and vascular age were also determined using the Framingham and SCORE criteria. Results: The mean values of all CVR scales and the prevalence of elevated values of these scales are higher in both AD and TL. The scale that most increases the risk of presenting both AD and TL is ALLY of Framingham vascular age. The CVR scales, in general, have a low predictive power for both AD and TL. Conclusions: There is a good association between the CVR scales analyzed and AD and TL. The value of these CVR scales for predicting AD and TL is low, with the exception of ALLY with the Framingham criteria.
引用
收藏
页码:9 / 15
页数:7
相关论文
共 50 条
  • [21] Association between atherogenic dyslipidemia and fournier's gangrene
    Akan, Serkan
    Urkmez, Ahmet
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2020, 66 (04): : 479 - 484
  • [22] Niacin and fibrates in atherogenic dyslipidemia: Pharmacotherapy to reduce cardiovascular risk
    Chapman, M. John
    Redfern, Jan S.
    McGovern, Mark E.
    Giral, Philippe
    PHARMACOLOGY & THERAPEUTICS, 2010, 126 (03) : 314 - 345
  • [23] Prediabetes with Hypertension and Dyslipidemia: Are They Triad of Future Cardiovascular Risk? Response
    Tao, Jun
    CARDIOVASCULAR DRUGS AND THERAPY, 2019, 33 (06) : 765 - 766
  • [24] Residual risk due to atherogenic dyslipidemia: lipid-related residual risk
    Diaz Rodriguez, Angel
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2012, 24 : 14 - 18
  • [25] Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver disease
    Alkhouri, Naim
    Carter-Kent, Christine
    Elias, Michael
    Feldstein, Ariel E.
    CLINICAL LIPIDOLOGY, 2011, 6 (03) : 305 - 314
  • [26] Understanding and managing the atherogenic dyslipidemia: the new frontier for cardiovascular risk reduction
    Lorenzatti, Alberto
    REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA, 2016, 45 : 6 - 12
  • [27] Association between atherogenic dyslipidemia and muscle quality defined by myosteatosis
    Kim, Hwi Seung
    Cho, Yun Kyung
    Kim, Myung Jin
    Kim, Eun Hee
    Lee, Min Jung
    Lee, Woo Je
    Kim, Hong-Kyu
    Jung, Chang Hee
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [28] Atherogenic Dyslipidemia and Residual Cardiovascular Risk in Statin-Treated Patients
    Sirimarco, Gaia
    Labreuche, Julien
    Bruckert, Eric
    Goldstein, Larry B.
    Fox, Kim M.
    Rothwell, Peter M.
    Amarenco, Pierre
    STROKE, 2014, 45 (05) : 1429 - 1436
  • [29] Association between atherogenic dyslipidemia and recurrent stroke risk in patients with different subtypes of ischemic stroke
    Zhao, Lu
    Wang, Ruihao
    Song, Bo
    Tan, Song
    Gao, Yuan
    Fang, Hui
    Lu, Jie
    Xu, Yuming
    INTERNATIONAL JOURNAL OF STROKE, 2015, 10 (05) : 752 - 758
  • [30] Atherogenic Dyslipidemia and Residual Cardiovascular Risk in Statin-Treated Patients
    Sirimarco, G.
    Labreuche, J.
    Bruckert, E.
    Goldstein, L. B.
    Fox, K. M.
    Rothwell, P. M.
    Amarenco, P.
    CEREBROVASCULAR DISEASES, 2014, 37 : 90 - 90